Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren for Triple RAAS Blockade in Diabetic Nephropathy
NCT00961207Phase 4Terminated
- Sponsor
- Cook County Health
- Start
- Aug 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aliskiren in diabetic nephropathy (DN), sponsored by Cook County Health. Primary endpoint: Reduction in albuminuria/proteinuria at 6 weeks. Started Aug 2009; status: terminated.
02
Drugs
aliskiren
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00961207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961207.